Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (Vaccinia-related kinase) activities

Molecular and Cellular Proteomics

Volumn 7, Issue 11, 2008, Pages 2199-2214

  Sanz García, Marta ^a   López Sánchez, Inmaculada ^a   Lazo, Pedro A ^a  

^a Salamanca Spain   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; PROTEIN SERINE THREONINE KINASE; RAN PROTEIN; REGULATOR OF CHROMOSOME CONDENSATION 1; UNCLASSIFIED DRUG; VACCINIA RELATED KINASE 1; VACCINIA RELATED KINASE 2;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; CELL CYCLE PROTEINS; CELL LINE; CELL NUCLEUS; DNA PRIMERS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; RAN GTP-BINDING PROTEIN; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 57049188372     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M700586-MCP200     Document Type: Article

References (63)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. The protein kinase complement of the human genome. (2002) Science 298, 1912-1934
2. Nezu, J., Oku, A., Jones, M. H., and Shimane, M. (1997) Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 45, 327-331
3. Lopez-Borges, S., and Lazo, P. A. (2000) The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 19, 3656-3664
4. Nichols, R. J., and Traktman, P. (2004) Characterization of three paralogous members of the mammalian vaccinia related kinase family. J. Biol. Chem. 279, 7934-7946
5. Vega, F. M., Gonzalo, P., Gaspar, M. L., and Lazo, P. A. (2003) Expression of the VRK (vaccinia-related kinase) gene family of p53 regulators in murine hematopoietic development. FEBS Lett. 544, 176-180
6. Santos, C. R., Rodriguez-Pinilla, M., Vega, F. M., Rodriguez-Peralto, J. L., Blanco, S., Sevilla, A., Valbuena, A., Hernandez, T., van Wijnen, A. J., Li, F., de Alava, E., Sanchez-Cespedes, M., and Lazo, P. A. (2006) VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma. Mol. Cancer Res. 4, 177-185
7. Valbuena, A., Lopez-Sanchez, I., Vega, F. M., Sevilla, A., Sanz-Garcia, M., Blanco, S., and Lazo, P. A. (2007) Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations. Arch. Biochem. Biophys. 465, 219-226
8. Blanco, S., Klimcakova, L., Vega, F. M., and Lazo, P. A. (2006) The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines. FEBS J. 273, 2487-2504
9. Barcia, R., Lopez-Borges, S., Vega, F. M., and Lazo, P. A. (2002) Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. Arch. Biochem. Biophys. 399, 1-5
10. Vega, F. M., Sevilla, A., and Lazo, P. A. (2004) Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol. Cell. Biol. 24, 10366-10380
11. Kwon, S. Y., Choi, Y. J., Kang, T. H., Lee, K. H., Cha, S. S., Kim, G. H., Lee, H. S., Kim, K. T., and Kim, K. J. (2005) Highly efficient protein expression and purification using bacterial hemoglobin fusion vector. Plasmid 53, 274-282
12. Valbuena, A., Vega, F. M., Blanco, S., and Lazo, P. A. (2006) p53 down-regulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop. Mol. Cell. Biol. 26, 4782-4793
13. Sevilla, A., Santos, C. R., Barcia, R., Vega, F. M., and Lazo, P. A. (2004) c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 23, 8950-8958
14. Sevilla, A., Santos, C. R., Vega, F. M., and Lazo, P. A. (2004) Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J. Biol. Chem. 279, 27458-27465
15. Nichols, R. J., Wiebe, M. S., and Traktman, P. (2006) The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol. Biol. Cell 17, 2451-2464
16. Gorjanacz, M., Klerkx, E. P., Galy, V., Santarella, R., Lopez-Iglesias, C., Askjaer, P., and Mattaj, I. W. (2008) Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly. EMBO J. 26, 132-143
17. Sazer, S. (2005) The view from Awaji island: past, present, and future of RCC1 and the Ran GTPase system. Dev. Cell 9, 729-733
18. Kang, T. H., Park, D. Y., Choi, Y. H., Kim, K. J., Yoon, H. S., and Kim, K. T. (2007) Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol. Cell. Biol. 27, 8533-8546
19. Valbuena, A., Lopez-Sanchez, I., and Lazo, P. A. (2008) Human VRK1 is an early response gene and its loss causes a block in cell cycle progression. PLoS ONE 3, e1642
20. Takai, Y., Sasaki, T., and Matozaki, T. (2001) Small GTP-binding proteins. Physiol. Rev. 81, 153-208
21. Dhillon, A. S., Hagan, S., Rath, O., and Kolch, W. (2007) MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290
22. McKay, M. M., and Morrison, D. K. (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26, 3113-3121
23. Kuersten, S., Ohno, M., and Mattaj, I. W. (2001) Nucleocytoplasmic transport: Ran, β and beyond. Trends Cell Biol. 11, 497-503
24. Ems-McClung, S. C., Zheng, Y., and Walczak, C. E. (2004) Importin α/β and Ran-GTP regulate XCTK2 microtubule binding through a bipartite nuclear localization signal. Mol. Biol. Cell 15, 46-57
25. Harel, A., and Forbes, D. J. (2004) Importin β: conducting a much larger cellular symphony. Mol. Cell 16, 319-330
26. Stewart, M. (2007) Molecular mechanism of the nuclear protein import cycle. Nat. Rev. Mol. Cell Biol. 8, 195-208
27. Clarke, P. R., and Zhang, C. (2008) Spatial and temporal coordination of mitosis by Ran GTPase. Nat. Rev. Mol. Cell Biol. 9, 464-477
28. Arnaoutov, A., and Dasso, M. (2003) The Ran GTPase regulates kinetochore function. Dev. Cell 5, 99-111
29. Li, H.-Y., and Zheng, Y. (2004) Phosphorylation of RCC1 in mitosis is essential for producing a high RanGTP concentration on chromosomes and for spindle assembly in mammalian cells. Genes Dev. 18, 512-527
30. Zhang, C., and Clarke, P. R. (2001) Roles of Ran-GTP and Ran-GDP in precursor vesicle recruitment and fusion during nuclear envelope assembly in a human cell-free system. Curr. Biol. 11, 208-212
31. Bischoff, F. R., and Ponstingl, H. (1991) Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1. Nature 354, 80-82
32. Kalab, P., Pralle, A., Isacoff, E. Y., Heald, R., and Weis, K. (2006) Analysis of a RanGTP-regulated gradient in mitotic somatic cells. Nature 440, 697-701
33. Clarke, P. R., and Zhang, C. (2001) Ran GTPase: a master regulator of nuclear structure and function during the eukaryotic cell division cycle? Trends Cell Biol. 11, 366-371
34. Tsai, M. Y., Wiese, C., Cao, K., Martin, O., Donovan, P., Ruderman, J., Prigent, C., and Zheng, Y. (2003) A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat. Cell Biol. 5, 242-248
35. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858
36. Quimby, B. B., and Dasso, M. (2003) The small GTPase Ran: interpreting the signs. Curr. Opin. Cell Biol. 15, 338-344
37. Lounsbury, K. M., Richards, S. A., Carey, K. L., and Macara, I. G. (1996) Effects on regulatory factor interactions and subcellular localization. J. Biol. Chem. 271, 32834-32841
38. Renault, L., Kuhlmann, J., Henkel, A., and Wittinghofer, A. (2001) Structural basis for guanine nucleoticle exchange on Ran by the regulator of chromosome condensation (RCC1). Cell 105, 245-255
39. Hutchins, J. R. A., Moore, W. J., Hood, F. E., Wilson, J. S. J., Andrews, P. D., Swedlow, J. R., and Clarke, P. R. (2004) Phosphorylation regulates the dynamic interaction of RCC1 with chromosomes during mitosis. Curr. Biol. 14, 1099-1104
40. Kang, T. H., and Kim, K. T. (2008) VRK3-mediated inactivation of ERK signaling in adult and embryonic rodent tissues. Biochim. Biophys. Acta 1783, 49-58
41. Kang, T. H., and Kim, K. T. (2006) Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase. Nat. Cell Biol. 8, 863-869
42. Tu, H., and Wigler, M. (1999) Genetic evidence for Pak1 autoinhibition and its release by Cdc42. Mol. Cell. Biol. 19, 602-611
43. Kumar, R., and Vadlamudi, R. K. (2002) Emerging functions of p2l-activated kinases in human cancer cells. J. Cell. Physiol. 193, 133-144
44. Kumar, R., Gururaj, A. E., and Barnes, C. J. (2006) p21-activated kinases in cancer. Nat Rev. Cancer 6, 459-471
45. Blanco, S., Santos, C., and Lazo, P. A. (2007) Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1. Mol. Cell. Biol. 27, 7273-7283
46. Blanco, S., Sanz-Garcia, M., Santos, C. R., and Lazo, P. A. (2008) Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein. PLoS ONE 3, e1660
47. Aihara, H., Nakagawa, T., Yasui, K., Ohta, T., Hirose, S., Dhomae, N., Takio, K., Kaneko, M., Takeshima, Y., Muramatsu, M., and Ito, T. (2004) Nu- cleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo. Genes Dev. 18, 877-888
48. Cullen, C. F., Brittle, A. L., Ito, T., and Ohkura, H. (2005) The conserved kinase NHK-1 is essential for mitotic progression and unifying acentrosomal meiotic spindles in Drosophila melanogaster. J. Cell Biol. 171, 593-602
49. Ivanovska, I., Khandan, T., Ito, T., and Orr-Weaver, T. L. (2005) A histone code in meiosis: the histone kinase, NHK-1, is required for proper chromosomal architecture in Drosophila oocytes. Genes Dev. 19, 2571-2582
50. Brittle, A. L., Nanba, Y., Ito, T., and Ohkura, H. (2007) Concerted action of Aurora B, Polo and NHK-1 kinases in centromere-specific histone 2A phosphorylation. Exp. Cell Res. 313, 2780-2785
51. Polioudaki, H., Markaki, Y., Kourmouli, N., Dialynas, G., Theodoropoulos, P. A., Singh, P. B., and Georgatos, S. D. (2004) Mitotic phosphorylation of histone H3 at threonine 3. FEBS Lett. 560, 39-44
52. Shoemaker, C. B., and Chalkley, R. (1978) An H3 histone-specific kinase isolated from bovine thymus chromatin. J. Biol. Chem. 253, 5802-5807
53. Chadee, D. N., Hendzel, M. J., Tylipski, C. P., Allis, C. D., Bazett-Jones, D. P., Wright, J. A., and Davie, J. R. (1999) Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts. J. Biol. Chem. 274, 24914-24920
54. Duncan, E. A., Anest, V., Cogswell, P., and Baldwin, A. S. (2006) The kinases MSK1 and MSK2 are required for epidermal growth factor-induced, but not tumor necrosis factor-induced, histone H3 Ser10 phosphorylation. J. Biol. Chem. 281, 12521-12525
55. Choi, H. S., Choi, B. Y., Cho, Y. Y., Mizuno, H., Kang, B. S., Bode, A. M., and Dong, Z. (2005) Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation. Cancer Res. 65, 5818-5827
56. Wei, Y., Yu, L., Bowen, J., Gorovsky, M. A., and Allis, C. D. (1999) Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 97, 99-109
57. Soloaga, A., Thomson, S., Wiggin, G. R., Rampersaud, N., Dyson, M. H., Hazzalin, C. A., Mahadevan, L. C., and Arthur, J. S. (2003) MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788-2797
58. Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T., and Gaynor, R. B. (2003) Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655-659
59. Dal, J., Sultan, S., Taylor, S. S., and Higgins, J. M. (2005) The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment. Genes Dev. 19, 472-488
60. Mahadevan, L. C., Willis, A. C., and Barratt, M. J. (1991) Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 65, 775-783
61. Ito, T. (2007) Role of histone modification in chromatin dynamics. J. Biochem. 141, 609-614
62. Zippo, A., De Robertis, A., Serafini, R., and Oliviero, S. (2007) PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-depenclent transcriptional activation and oncogenic transformation. Nat. Cell Biol. 9, 932-944
63. Fuller, B. G., Lampson, M. A., Foley, E. A., Rosasco-Nitcher, S., Le, K. V., Tobelmann, P., Brautigan, D. L., Stukenberg, P. T., and Kapoor, T. M. (2008) Midzone activation of aurora B in anaphase produces an intracellular phosphorylation gradient. Nature 453, 1132-1136